Review



s-11 non-contact microarray printer  (SCIENION)


Bioz Verified Symbol SCIENION is a verified supplier
Bioz Manufacturer Symbol SCIENION manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    SCIENION s-11 non-contact microarray printer
    S 11 Non Contact Microarray Printer, supplied by SCIENION, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/contact+microarray+printer/noncontact+microarray+printer/us12038446-634-19-19
    Average 90 stars, based on 1 article reviews
    s-11 non-contact microarray printer - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Microarray:

    Article Title: Asymmetrical Biantennary Glycans Prepared by a Stop-and-Go Strategy Reveal Receptor Binding Evolution of Human Influenza A Viruses
    Article Snippet: .. The glycans, which have an α-amine at the anomeric asparagine moiety, were printed on amine reactive NHS activated glass slides using a noncontact microarray printer ( S3 , Scienion, Inc.). ..

    Article Title: Architectural Modification of Conformal PEG-Bottlebrush Coatings Minimizes Anti-PEG Antigenicity While Preserving Stealth Properties
    Article Snippet: .. Microarray-based indirect sandwich immunoassays (ISIAs) against anti-HIV p24 Abs on POEGMA. (A) anti-APA ISIA: Microarrays of PEGylated BSA (Life Diagnostics PBSA-00) were prepared by printing onto surfaces with a noncontact microarray printer (Scienion sciFlEXARRAYER S11) at a concentration of 1 mg/mL as microspots and then placed in a vacuum dessicator overnight. .. Next, these assays were run against serial dilutions of pAPA1 (ThermoFisher PA5–32247) spiked into calf serum and incubated for 1 h. The surfaces were then washed 3 times and then exposed to a 1 μg/mL solution of Cy5-donkey-anti-rabbit antibody (R&D Systems) for 30 min.

    Article Title: Architectural Modification of Conformal PEG-Bottlebrush Coatings Minimizes Anti-PEG Antigenicity While Preserving Stealth Properties
    Article Snippet: .. (A) anti-APA ISIA: Microarrays of PEGylated BSA (Life Diagnostics PBSA-00) were prepared by printing onto surfaces with a noncontact microarray printer (Scienion sciFlEXARRAYER S11) at a concentration of 1 mg/mL as microspots and then placed in a vacuum dessicator overnight. .. Next, these assays were run against serial dilutions of pAPA1 (ThermoFisher PA5–32247) spiked into calf serum and incubated for 1 h. The surfaces were then washed 3 times and then exposed to a 1 μg/mL solution of Cy5-donkey-anti-rabbit antibody (R&D Systems) for 30 min.

    Article Title: Surfaces having reduced non-specific binding and antigenicity
    Article Snippet: .. Microarray-Based Indirect Sandwich Immunoassays (ISIAs) Against Anti-HIV p24 Abs on POEGMA Anti-APA ISIA Microarrays of PEGylated BSA (Life Diagnostics PBSA-00) were prepared by printing onto surfaces with a noncontact microarray printer (Scienion sciFIEXARRAYER S11) at a concentration of 1 mg/mL as microspots and then placed in a vacuum dessicator overnight. .. Next, these assays were run against serial dilutions of pAPA1 (ThermoFisher PA5-32247) spiked into calf serum and incubated for 1 h. The surfaces were then washed 3 times and then exposed to a 1 μg/mL solution of Cy5-donkey-anti-rabbit antibody (R&D Systems) for 30 min.

    other:

    Article Title: Glycan Profiling Analysis of Equine Amniotic Progenitor Mesenchymal Cells and Their Derived Extracellular Microvesicles.
    Article Snippet: Salvatore Desantis, Gianluca Accogli, Maria Albrizio, RobertaRossi, Fausto Cremonesi, Anna Lange Consiglio Section of Veterinary Clinics and Animal Productions, Department of Emergency and Organ Transplantation (DETO), University of Bari Aldo Moro, S.P.. Casamassima Km.. 3, 70010 Valenzano (Ba), Italy.

    Article Title: Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
    Article Snippet: Briefly, the antigens were spotted on epoxy-activated glass substrates (in-house produced epoxyhexyltriethoxysilane (EHTES) activated epoxy slides) using a Scienion S-11 non-contact microarray printer (Scienion AG, Germany).

    Article Title: Methods and compositions for diagnosing brain injury or neurodegeneration
    Article Snippet: Antigens and Serum Testing 228 different antigens were spotted on in-house produced epoxyhexyltriethoxysilane (EHTES) activated epoxy slides using a Scienion S-11 non-contact microarray printer (Scienion AG, Germany).

    Article Title: Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
    Article Snippet: Briefly, the antigens were spotted on epoxy-activated glass substrates (in-house produced epoxyhexyltriethoxysilane (EHTES) activated epoxy slides) using a Scienion S-11 non-contact microarray printer (Scienion AG, Germany).

    Concentration Assay:

    Article Title: Architectural Modification of Conformal PEG-Bottlebrush Coatings Minimizes Anti-PEG Antigenicity While Preserving Stealth Properties
    Article Snippet: .. Microarray-based indirect sandwich immunoassays (ISIAs) against anti-HIV p24 Abs on POEGMA. (A) anti-APA ISIA: Microarrays of PEGylated BSA (Life Diagnostics PBSA-00) were prepared by printing onto surfaces with a noncontact microarray printer (Scienion sciFlEXARRAYER S11) at a concentration of 1 mg/mL as microspots and then placed in a vacuum dessicator overnight. .. Next, these assays were run against serial dilutions of pAPA1 (ThermoFisher PA5–32247) spiked into calf serum and incubated for 1 h. The surfaces were then washed 3 times and then exposed to a 1 μg/mL solution of Cy5-donkey-anti-rabbit antibody (R&D Systems) for 30 min.

    Article Title: Architectural Modification of Conformal PEG-Bottlebrush Coatings Minimizes Anti-PEG Antigenicity While Preserving Stealth Properties
    Article Snippet: .. (A) anti-APA ISIA: Microarrays of PEGylated BSA (Life Diagnostics PBSA-00) were prepared by printing onto surfaces with a noncontact microarray printer (Scienion sciFlEXARRAYER S11) at a concentration of 1 mg/mL as microspots and then placed in a vacuum dessicator overnight. .. Next, these assays were run against serial dilutions of pAPA1 (ThermoFisher PA5–32247) spiked into calf serum and incubated for 1 h. The surfaces were then washed 3 times and then exposed to a 1 μg/mL solution of Cy5-donkey-anti-rabbit antibody (R&D Systems) for 30 min.

    Article Title: Surfaces having reduced non-specific binding and antigenicity
    Article Snippet: .. Microarray-Based Indirect Sandwich Immunoassays (ISIAs) Against Anti-HIV p24 Abs on POEGMA Anti-APA ISIA Microarrays of PEGylated BSA (Life Diagnostics PBSA-00) were prepared by printing onto surfaces with a noncontact microarray printer (Scienion sciFIEXARRAYER S11) at a concentration of 1 mg/mL as microspots and then placed in a vacuum dessicator overnight. .. Next, these assays were run against serial dilutions of pAPA1 (ThermoFisher PA5-32247) spiked into calf serum and incubated for 1 h. The surfaces were then washed 3 times and then exposed to a 1 μg/mL solution of Cy5-donkey-anti-rabbit antibody (R&D Systems) for 30 min.



    Similar Products

    non contact inkjet microarray printer  (SCIENION)
    95
    SCIENION non contact inkjet microarray printer
    The VANC-D4 assay (A) Fabrication of the VANC-D4 assay. SI-ATRP is used to grow POEGMA-co-GMA brushes on glass slides. Following SI-ATRP, VANC-BSA is <t>inkjet</t> printed into the polymer brush to create stable spots and fluorescently labeled anti-VANC antibodies (termed dAb) are printed on trehalose pads to create labile spots. (B) Sequential steps of the VANC-D4 assay. The steps of the VANC-D4 are (i) dispensing a blood sample on the surface, (ii) dissolution of the trehalose pads to release the fluorescently labeled dAb into solution, (iii) diffusion of the labeled dAb in the sample volume, (iv) detection of fluorescence signal from the antibody bound to immobilized VANC-BSA. (C) Representative VANC-D4 assay response in the presence of (i) no drug, (ii) low drug, and (iii) high drug concentration. (D) VANC monitoring across its clinical range using VANC-spiked whole blood diluted 100-fold in running buffer, analyzed in triplicate. The clinical range for the test is 1–45 μg/mL. Intensity values are shown, with error bars that represent the standard error of the means for n = 3 separate runs. The LOD for the presented dose-response curve was calculated to be 0.8 μg/mL.
    Non Contact Inkjet Microarray Printer, supplied by SCIENION, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/contact+microarray+printer/sciFLEXARRAYER+S12/pmc13380757-243-19-23
    Average 95 stars, based on 1 article reviews
    non contact inkjet microarray printer - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    contact microarray printer smartarrayer 136  (CapitalBio Corporation)
    90
    CapitalBio Corporation contact microarray printer smartarrayer 136
    The VANC-D4 assay (A) Fabrication of the VANC-D4 assay. SI-ATRP is used to grow POEGMA-co-GMA brushes on glass slides. Following SI-ATRP, VANC-BSA is <t>inkjet</t> printed into the polymer brush to create stable spots and fluorescently labeled anti-VANC antibodies (termed dAb) are printed on trehalose pads to create labile spots. (B) Sequential steps of the VANC-D4 assay. The steps of the VANC-D4 are (i) dispensing a blood sample on the surface, (ii) dissolution of the trehalose pads to release the fluorescently labeled dAb into solution, (iii) diffusion of the labeled dAb in the sample volume, (iv) detection of fluorescence signal from the antibody bound to immobilized VANC-BSA. (C) Representative VANC-D4 assay response in the presence of (i) no drug, (ii) low drug, and (iii) high drug concentration. (D) VANC monitoring across its clinical range using VANC-spiked whole blood diluted 100-fold in running buffer, analyzed in triplicate. The clinical range for the test is 1–45 μg/mL. Intensity values are shown, with error bars that represent the standard error of the means for n = 3 separate runs. The LOD for the presented dose-response curve was calculated to be 0.8 μg/mL.
    Contact Microarray Printer Smartarrayer 136, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/contact+microarray+printer/contact+microarray+printer+smartarrayer+136/pm40249703-755-24-29
    Average 90 stars, based on 1 article reviews
    contact microarray printer smartarrayer 136 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    sciflexarrayer s1 non-contact microarray printer  (SCIENION)
    90
    SCIENION sciflexarrayer s1 non-contact microarray printer
    The VANC-D4 assay (A) Fabrication of the VANC-D4 assay. SI-ATRP is used to grow POEGMA-co-GMA brushes on glass slides. Following SI-ATRP, VANC-BSA is <t>inkjet</t> printed into the polymer brush to create stable spots and fluorescently labeled anti-VANC antibodies (termed dAb) are printed on trehalose pads to create labile spots. (B) Sequential steps of the VANC-D4 assay. The steps of the VANC-D4 are (i) dispensing a blood sample on the surface, (ii) dissolution of the trehalose pads to release the fluorescently labeled dAb into solution, (iii) diffusion of the labeled dAb in the sample volume, (iv) detection of fluorescence signal from the antibody bound to immobilized VANC-BSA. (C) Representative VANC-D4 assay response in the presence of (i) no drug, (ii) low drug, and (iii) high drug concentration. (D) VANC monitoring across its clinical range using VANC-spiked whole blood diluted 100-fold in running buffer, analyzed in triplicate. The clinical range for the test is 1–45 μg/mL. Intensity values are shown, with error bars that represent the standard error of the means for n = 3 separate runs. The LOD for the presented dose-response curve was calculated to be 0.8 μg/mL.
    Sciflexarrayer S1 Non Contact Microarray Printer, supplied by SCIENION, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/contact+microarray+printer/noncontact+microarray+spotter+sciflexarrayer+s12/pmc11673104__ja4c08817_si_001-501-8-7
    Average 90 stars, based on 1 article reviews
    sciflexarrayer s1 non-contact microarray printer - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    s-11 non-contact microarray printer  (SCIENION)
    90
    SCIENION s-11 non-contact microarray printer
    The VANC-D4 assay (A) Fabrication of the VANC-D4 assay. SI-ATRP is used to grow POEGMA-co-GMA brushes on glass slides. Following SI-ATRP, VANC-BSA is <t>inkjet</t> printed into the polymer brush to create stable spots and fluorescently labeled anti-VANC antibodies (termed dAb) are printed on trehalose pads to create labile spots. (B) Sequential steps of the VANC-D4 assay. The steps of the VANC-D4 are (i) dispensing a blood sample on the surface, (ii) dissolution of the trehalose pads to release the fluorescently labeled dAb into solution, (iii) diffusion of the labeled dAb in the sample volume, (iv) detection of fluorescence signal from the antibody bound to immobilized VANC-BSA. (C) Representative VANC-D4 assay response in the presence of (i) no drug, (ii) low drug, and (iii) high drug concentration. (D) VANC monitoring across its clinical range using VANC-spiked whole blood diluted 100-fold in running buffer, analyzed in triplicate. The clinical range for the test is 1–45 μg/mL. Intensity values are shown, with error bars that represent the standard error of the means for n = 3 separate runs. The LOD for the presented dose-response curve was calculated to be 0.8 μg/mL.
    S 11 Non Contact Microarray Printer, supplied by SCIENION, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/contact+microarray+printer/noncontact+microarray+printer/us12038446-634-19-19
    Average 90 stars, based on 1 article reviews
    s-11 non-contact microarray printer - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    sciflexarrayer s3 non contact microarray printer  (SCIENION)
    96
    SCIENION sciflexarrayer s3 non contact microarray printer
    The VANC-D4 assay (A) Fabrication of the VANC-D4 assay. SI-ATRP is used to grow POEGMA-co-GMA brushes on glass slides. Following SI-ATRP, VANC-BSA is <t>inkjet</t> printed into the polymer brush to create stable spots and fluorescently labeled anti-VANC antibodies (termed dAb) are printed on trehalose pads to create labile spots. (B) Sequential steps of the VANC-D4 assay. The steps of the VANC-D4 are (i) dispensing a blood sample on the surface, (ii) dissolution of the trehalose pads to release the fluorescently labeled dAb into solution, (iii) diffusion of the labeled dAb in the sample volume, (iv) detection of fluorescence signal from the antibody bound to immobilized VANC-BSA. (C) Representative VANC-D4 assay response in the presence of (i) no drug, (ii) low drug, and (iii) high drug concentration. (D) VANC monitoring across its clinical range using VANC-spiked whole blood diluted 100-fold in running buffer, analyzed in triplicate. The clinical range for the test is 1–45 μg/mL. Intensity values are shown, with error bars that represent the standard error of the means for n = 3 separate runs. The LOD for the presented dose-response curve was calculated to be 0.8 μg/mL.
    Sciflexarrayer S3 Non Contact Microarray Printer, supplied by SCIENION, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/contact+microarray+printer/sciFLEXARRAYER+S3/pmc10900492__au3c00695_si_001-339-7-6
    Average 96 stars, based on 1 article reviews
    sciflexarrayer s3 non contact microarray printer - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    contact microarray printer  (BioDot Inc)
    90
    BioDot Inc contact microarray printer
    The VANC-D4 assay (A) Fabrication of the VANC-D4 assay. SI-ATRP is used to grow POEGMA-co-GMA brushes on glass slides. Following SI-ATRP, VANC-BSA is <t>inkjet</t> printed into the polymer brush to create stable spots and fluorescently labeled anti-VANC antibodies (termed dAb) are printed on trehalose pads to create labile spots. (B) Sequential steps of the VANC-D4 assay. The steps of the VANC-D4 are (i) dispensing a blood sample on the surface, (ii) dissolution of the trehalose pads to release the fluorescently labeled dAb into solution, (iii) diffusion of the labeled dAb in the sample volume, (iv) detection of fluorescence signal from the antibody bound to immobilized VANC-BSA. (C) Representative VANC-D4 assay response in the presence of (i) no drug, (ii) low drug, and (iii) high drug concentration. (D) VANC monitoring across its clinical range using VANC-spiked whole blood diluted 100-fold in running buffer, analyzed in triplicate. The clinical range for the test is 1–45 μg/mL. Intensity values are shown, with error bars that represent the standard error of the means for n = 3 separate runs. The LOD for the presented dose-response curve was calculated to be 0.8 μg/mL.
    Contact Microarray Printer, supplied by BioDot Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/contact+microarray+printer/contact+microarray+printer/pmc10688221__ac3c03887_si_001-39-13-16
    Average 90 stars, based on 1 article reviews
    contact microarray printer - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    The VANC-D4 assay (A) Fabrication of the VANC-D4 assay. SI-ATRP is used to grow POEGMA-co-GMA brushes on glass slides. Following SI-ATRP, VANC-BSA is inkjet printed into the polymer brush to create stable spots and fluorescently labeled anti-VANC antibodies (termed dAb) are printed on trehalose pads to create labile spots. (B) Sequential steps of the VANC-D4 assay. The steps of the VANC-D4 are (i) dispensing a blood sample on the surface, (ii) dissolution of the trehalose pads to release the fluorescently labeled dAb into solution, (iii) diffusion of the labeled dAb in the sample volume, (iv) detection of fluorescence signal from the antibody bound to immobilized VANC-BSA. (C) Representative VANC-D4 assay response in the presence of (i) no drug, (ii) low drug, and (iii) high drug concentration. (D) VANC monitoring across its clinical range using VANC-spiked whole blood diluted 100-fold in running buffer, analyzed in triplicate. The clinical range for the test is 1–45 μg/mL. Intensity values are shown, with error bars that represent the standard error of the means for n = 3 separate runs. The LOD for the presented dose-response curve was calculated to be 0.8 μg/mL.

    Journal: iScience

    Article Title: A rapid point-of-care test for vancomycin monitoring at the clinical bedside

    doi: 10.1016/j.isci.2026.116064

    Figure Lengend Snippet: The VANC-D4 assay (A) Fabrication of the VANC-D4 assay. SI-ATRP is used to grow POEGMA-co-GMA brushes on glass slides. Following SI-ATRP, VANC-BSA is inkjet printed into the polymer brush to create stable spots and fluorescently labeled anti-VANC antibodies (termed dAb) are printed on trehalose pads to create labile spots. (B) Sequential steps of the VANC-D4 assay. The steps of the VANC-D4 are (i) dispensing a blood sample on the surface, (ii) dissolution of the trehalose pads to release the fluorescently labeled dAb into solution, (iii) diffusion of the labeled dAb in the sample volume, (iv) detection of fluorescence signal from the antibody bound to immobilized VANC-BSA. (C) Representative VANC-D4 assay response in the presence of (i) no drug, (ii) low drug, and (iii) high drug concentration. (D) VANC monitoring across its clinical range using VANC-spiked whole blood diluted 100-fold in running buffer, analyzed in triplicate. The clinical range for the test is 1–45 μg/mL. Intensity values are shown, with error bars that represent the standard error of the means for n = 3 separate runs. The LOD for the presented dose-response curve was calculated to be 0.8 μg/mL.

    Article Snippet: Following polymerization, D4 assays were fabricated using non-contact inkjet printing methods as described elsewhere., VANC-BSA was printed using a non-contact inkjet microarray printer (Scienion, sciFLEXARRAYER Type S12).

    Techniques: Polymer, Labeling, Dissolution, Diffusion-based Assay, Fluorescence, Concentration Assay